Allermi

Seed
allermi.com Biotech & Healthcare
Total Funding $3.5M
Latest Round $3.5M Seed
Last Announced Mar 16, 2023
Investors Undisclosed
Decision Makers 5 Verified

About Allermi

Patent-pending custom allergy treatment designed by board-certified allergists, backed by science, and delivered right to your door

Sectors & Market Categories

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Seed
Global Headquarters Undisclosed
Tracked Since Oct 1, 2026

Web & Domain Identity

Official Website allermi.com
Domain Registered Date Aug 27, 2019

Social & Network Presence

X / Twitter Profile @GetAllermi (59 followers) Created on Nov 2022
LinkedIn Corporate Not linked

Company Milestones & Timeline

3 Events
  1. Capital Raise

    Raised $3,500,000 · Seed

    fundraisingfox.com

  2. Milestone

    X account created (@GetAllermi)

    59 followers

  3. Milestone

    Website domain registered

    allermi.com

Investors & Backers

Investor firms and individual backers were not publicly disclosed in available round filings for Allermi.

Funding History

1 Round
Seed · Mar 16, 2023

Founders & Leadership

1

Shani שני Bocian Steinberg

Co-Founder

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts